Lattice Biologics (LBL) Stock Price, News & Analysis

Company Overview

Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologic products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops novel amniotic fluid-based products, such as AmnioBoost and AmnioBlast. The company also offers traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix allografts. Its products are used in a range of applications, including enhancing fusion in spine surgery and breast reconstruction post mastectomy, promotion of bone regeneration in foot and ankle surgery, promotion of skull healing following neurosurgery, enhancing wound repair in burn victims, hernia repair, and subchondral bone defect repair in knee and other joint surgeries, as well as sports medicine indications, such as anterior and posterior cruciate ligament repair. The company is headquartered in Belgrade, Montana.

Key Stats

• Today's Range: C$0.04 to C$0.04
• 50-Day Range: C$0.04 to C$0.04
• 52-Week Range: C$0.03 to C$0.13
• Volume: 114,000 shs
• Average Volume: 468,022 shs
• Market Capitalization: C$5.13 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LBL Stock Analysis - Frequently Asked Questions

How have LBL shares performed this year?

Lattice Biologics' stock was trading at C$0.04 on January 1st, 2025. Since then, LBL shares have increased by 0.0% and is now trading at C$0.04.

How do I buy shares of Lattice Biologics?

Shares of LBL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Lattice Biologics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Lattice Biologics investors own include 50904 (GRC.V) (GRC), Air Canada (AC), Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Antibe Therapeutics (ATE) and BioCryst Pharmaceuticals (BCRX).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: CVE:LBL
• CIK: N/A
• Web: www.latticebiologics.com
• Phone: +1-604-2356701
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.02
• Quick Ratio: 0.02

Sales & Book Value

• Annual Sales: C$1.56 million
• Price / Sales: 3.29
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: C$0.00 per share
• Price / Book: 40.00

Miscellaneous

• Outstanding Shares: 128,218,000
• Free Float: N/A
• Market Cap: C$5.13 million
• Optionable: Not Optionable
• Beta: N/A